20
Granules India Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for World-class facilities for APIs, PFIs & FDFs, Serving customers in over 75+ countries.
One of their significant offerings is Guaifenesin, BPL site, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2021-332 - Rev 00
This Chemical Type CEP, issued on December 10, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 615 associated with this CEP further emphasizes